Inhibiting the Ca(2+) Influx Induced by Human CSF

One potential therapeutic strategy for Alzheimer’s disease (AD) is to use antibodies that bind to small soluble protein aggregates to reduce their toxic effects. However, these therapies are rarely tested in human CSF before clinical trials because of the lack of sensitive methods that enable the me...

Descripción completa

Detalles Bibliográficos
Autores principales: Drews, Anna, De, Suman, Flagmeier, Patrick, Wirthensohn, David C., Chen, Wei-Hsin, Whiten, Daniel R., Rodrigues, Margarida, Vincke, Cécile, Muyldermans, Serge, Paterson, Ross W., Slattery, Catherine F., Fox, Nick C., Schott, Jonathan M., Zetterberg, Henrik, Dobson, Christopher M., Gandhi, Sonia, Klenerman, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745229/
https://www.ncbi.nlm.nih.gov/pubmed/29241555
http://dx.doi.org/10.1016/j.celrep.2017.11.057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745229/
https://www.ncbi.nlm.nih.gov/pubmed/29241555
http://dx.doi.org/10.1016/j.celrep.2017.11.057

Ejemplares similares